| 臺大學術典藏 |
2020-04-28T07:25:19Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.;Su W.-C.;Yen C.-J.;Chih-Hung Hsu;Su W.-P.;Yeh K.-H.;Lu Y.-S.;Cheng A.-L.;Huang D.C.-L.;Fritsch H.;Voss F.;Taube T.;Yang J.C.-H.; Lin C.-C.; Su W.-C.; Yen C.-J.; CHIH-HUNG HSU; Su W.-P.; Yeh K.-H.; Lu Y.-S.; Cheng A.-L.; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-04-10T12:51:30Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma
|
Chiun Hsu;Huang C.-S.;Chao T.-Y.;Lu Y.-S.;Bu C.-F.;Chen M.M.;Chang K.-J.;Cheng A.-L.; Chiun Hsu; Huang C.-S.; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; Chang K.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:29Z |
Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
Li C.-C.; Kuo S.-H.; Yeh K.-H.; Yang C.-H.; Hsu C.-H.; Wu C.-Y.; Cheng A.-L.; Lu Y.-S.;Chiun Hsu;Li C.-C.;Kuo S.-H.;Yeh K.-H.;Yang C.-H.;Hsu C.-H.;Wu C.-Y.;Cheng A.-L.; Lu Y.-S.; Chiun Hsu |
| 臺大學術典藏 |
2020-04-10T12:51:26Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'Ang H.-J.;Wang C.-C.;Cheng A.-L.;Chiun Hsu;Lu Y.-S.;Chang M.-C.;Lin J.-T.;Wang H.-P.;Shiah H.-S.;Liu T.-W.;Chang J.-Y.;Whang-Peng J.;Chen L.-T.; Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; Chiun Hsu; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2020-04-10T12:51:21Z |
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
|
Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Chiun Hsu; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:21Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; Chiun Hsu; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:15Z |
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma
|
Cheng A.-L.; Hsu C.-H.; Lin Z.-Z.; Chiun Hsu; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Shao Y.-Y. |
| 臺大學術典藏 |
2020-04-10T12:51:13Z |
The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines
|
Chen W.-W.; Chang D.-Y.; Huang S.-M.; Lin C.-H.; Chiun Hsu; Lin M.-H.; Huang C.-S.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:13Z |
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
|
Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; Yang S.-H.; Huang S.-M.; Chiun Hsu; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:16:13Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
YU-YUN SHAO; Kuo K.-T.; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; Chang K.-J.; Lin C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:16:12Z |
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma
|
YU-YUN SHAO; Lin Z.-Z.; Hsu C.; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:15:56Z |
Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS
|
Lu Y.-S.; Lin C.-H.; Tsai I.-L.; Kuo C.-H.; YU-YUN SHAO; Chiu H.-H.;Liao H.-W.;Yu-Yun Shao;Lu Y.-S.;Lin C.-H.;Tsai I.-L.;Kuo C.-H.; Chiu H.-H.; Liao H.-W. |
| 臺大學術典藏 |
2020-03-27T02:23:27Z |
O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers
|
Lin C.-H.; Cheng A.-L.; Tseng S.-H.; Tseng H.-M.; Wu P.-F.;Kuo K.-T.;Lu-Ting Kuo;Lin Y.-T.;Lee W.-C.;Lu Y.-S.;Yang C.-H.;Wu R.-M.;Tu Y.-K.;Tasi J.-C.;Tseng H.-M.;Tseng S.-H.;Cheng A.-L.;Lin C.-H.; Wu P.-F.; Kuo K.-T.; LU-TING KUO; Lin Y.-T.; Lee W.-C.; Lu Y.-S.; Yang C.-H.; Wu R.-M.; Tu Y.-K.; Tasi J.-C. |
| 臺大學術典藏 |
2020-03-27T02:03:49Z |
Pneumatosis coli after etoposide chemotherapy for breast cancer
|
Lu Y.-S.; Shih I.-L.; Shih I.-L.;Lu Y.-S.;Wang H.-P.;Kao-Lang Liu; Wang H.-P.; KAO-LANG LIU |
| 臺大學術典藏 |
2020-03-24T04:02:56Z |
The Association of Infrared Imaging Findings of the Breast with Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status of Breast Cancer
|
Wang J. ;Shih T.T.F. ;Yen R.-F. ;Lu Y.-S. ;Chen C.-Y. ;Mao T.-L. ;Lin C.-H. ;Wen-Hung Kuo ;Tsai Y.-S. ;Chang K.-J. ;Chien K.-L.; Wang J.; Shih T.T.F.; Yen R.-F.; Lu Y.-S.; Chen C.-Y.; Mao T.-L.; Lin C.-H.; WEN-HUNG KUO; Tsai Y.-S.; Chang K.-J.; Chien K.-L. |
| 臺大學術典藏 |
2020-03-24T04:02:55Z |
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era
|
Lin C.H.; Chen I.C.; Chen I.C. ;Lin C.H. ;Huang C.S. ;Lien H.C. ;Hsu C. ;Wen-Hung Kuo ;Lu Y.S. ;Cheng A.L.; Huang C.S.; Lien H.C.; Hsu C.; WEN-HUNG KUO; Lu Y.S.; Cheng A.L. |
| 臺大學術典藏 |
2020-03-24T04:02:54Z |
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer
|
Cheng A.-L.; Lin C.-H.; Sargeant A.M.; Lu Y.-S.; Bai L.-Y.; Liu T.-P.; WEN-HUNG KUO; Lin P.-H.; Huang A.-C.; Chien Y.-H.; Hsieh F.-J.; Hwu W.-L.; Chang K.-J. |
| 臺大學術典藏 |
2020-03-24T04:02:47Z |
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
|
Wang M.-Y.; Kuo S.-H.; Lin C.-H.; Lu Y.-S.; WEN-HUNG KUO; Huang A.-C.; Lin P.-H.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; Yu S.-L.; Chang K.-J.; Chen P.-L.; Ni Y.-H.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-24T04:02:47Z |
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays
|
Cheng A.-L.; Lu Y.-S.; Chen W.-W.; Chang C.-H.; Wang M.-Y.; Chang D.-Y.; Wu P.-F.; Wang C.-C.; Kuo K.-T.; WEN-HUNG KUO; Hu F.-C.; Huang C.-S.; Chen I.-C.; Lin C.-H. |
| 臺大學術典藏 |
2020-03-24T04:02:47Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lu Y.-S.; Cheng A.-L.; Chen C.-J.; Kuo S.-H.; Wu P.-F.; Chen I.-C.; Chen W.-W.; Lin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; WEN-HUNG KUO; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T. |
| 臺大學術典藏 |
2020-03-24T04:02:44Z |
Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1–2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy
|
Lai S.-F.; Chen Y.-H.; WEN-HUNG KUO; Lien H.-C.; Wang M.-Y.; Lu Y.-S.; Lo C.; Kuo S.-H.; Cheng A.-L.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-23T07:19:36Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Hsu C.;Chiun-Sheng Huang;Chao T.-Y.;Lu Y.-S.;Bu C.-F.;Chen M.M.;Chang K.-J.;Cheng A.-L.; Hsu C.; CHIUN-SHENG HUANG; Chao T.-Y.; Lu Y.-S.; Bu C.-F.; Chen M.M.; Chang K.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-23T07:19:35Z |
Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI
|
Chang Y.-C.;Chiun-Sheng Huang;Liu Y.-J.;Chen J.-H.;Lu Y.-S.;Tseng W.-Y.I.; Chang Y.-C.; CHIUN-SHENG HUANG; Liu Y.-J.; Chen J.-H.; Lu Y.-S.; Tseng W.-Y.I. |
| 臺大學術典藏 |
2020-03-23T07:19:33Z |
Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms
|
Lien H.-C.;Lu Y.-S.;Cheng A.-L.;Chang W.-C.;Jeng Y.-M.;Kuo Y.-H.;Chiun-Sheng Huang;Chang K.-J.;Yao Y.-T.; Lien H.-C.; Lu Y.-S.; Cheng A.-L.; Chang W.-C.; Jeng Y.-M.; Kuo Y.-H.; CHIUN-SHENG HUANG; Chang K.-J.; Yao Y.-T. |
| 臺大學術典藏 |
2020-03-23T07:19:32Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Hsu C.; Yeh K.-H.; Wu C.-Y.; CHIUN-SHENG HUANG; Yang C.-H.; Lu Y.-S.; Hsu C.-H.; Cheng A.-L.; Lin C.-C. |
| 臺大學術典藏 |
2020-03-23T07:19:29Z |
The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers
|
Chang K.-J.; Lu Y.-S.; Lin C.-H.; Shen C.-Y.; You S.-L.; Yang S.-Y.; Kuo S.-H.; Lien H.-C.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2020-03-23T07:19:28Z |
Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy
|
CHIUN-SHENG HUANG; Chang K.-J.; Cheng A.-L.; Lin C.-H.;Lien H.-C.;Hu F.-C.;Lu Y.-S.;Kuo S.-H.;Wu L.-C.;You S.-L.;Cheng A.-L.;Chang K.-J.;Chiun-Sheng Huang; Lin C.-H.; Lien H.-C.; Hu F.-C.; Lu Y.-S.; Kuo S.-H.; Wu L.-C.; You S.-L. |
| 臺大學術典藏 |
2020-03-23T07:19:27Z |
Unique features of breast cancer in Asian women-Breast cancer in Taiwan as an example
|
Chiun-Sheng Huang;Lin C.-H.;Lu Y.-S.;Shen C.-Y.; CHIUN-SHENG HUANG; Lin C.-H.; Lu Y.-S.; Shen C.-Y. |
| 臺大學術典藏 |
2020-03-23T07:19:27Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Cheng A.-L.; Lin C.-H.; Chang K.-J.; Kuo W.-H.; Lee W.-C.; Hsu C.; CHIUN-SHENG HUANG; Liau J.-Y.; Lu Y.-S.; Shao Y.-Y.;Kuo K.-T.;Hu F.-C.;Lu Y.-S.;Chiun-Sheng Huang;Liau J.-Y.;Lee W.-C.;Hsu C.;Kuo W.-H.;Chang K.-J.;Lin C.-H.;Cheng A.-L.; Shao Y.-Y.; Kuo K.-T.; Hu F.-C. |
| 臺大學術典藏 |
2020-03-23T07:19:26Z |
Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation
|
Lin P.-H.;Lu Y.-S.;Lin C.-H.;Chang D.-Y.;Chiun-Sheng Huang;Cheng A.-L.;Yeh K.-H.; Lin P.-H.; Lu Y.-S.; Lin C.-H.; Chang D.-Y.; CHIUN-SHENG HUANG; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-03-23T07:19:22Z |
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era
|
Cheng A.L.; Lu Y.S.; Kuo W.H.; Hsu C.; Lien H.C.; CHIUN-SHENG HUANG; Lin C.H.; Chen I.C.; Chen I.C.;Lin C.H.;Chiun-Sheng Huang;Lien H.C.;Hsu C.;Kuo W.H.;Lu Y.S.;Cheng A.L. |
| 臺大學術典藏 |
2020-03-23T07:19:22Z |
Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients?
|
Cheng A.-L.; Chang K.-J.; Kuo W.-H.; Chang D.-Y.; Lin P.-H.; You S.-L.; Wang C.-C.; Kuo K.-T.; Lu Y.-S.; CHIUN-SHENG HUANG; Lin C.-H.; Lin C.-H.;Lu Y.-S.;Chiun-Sheng Huang;Kuo K.-T.;Wang C.-C.;You S.-L.;Lin P.-H.;Chang D.-Y.;Kuo W.-H.;Chang K.-J.;Cheng A.-L. |
| 臺大學術典藏 |
2020-03-23T07:19:21Z |
The emerging epidemic of estrogen-related cancers in young women in a developing Asian country
|
Cheng A.-L.; You S.-L.; Lai M.-S.; Cheng W.-F.; CHIUN-SHENG HUANG; Kuo K.-T.; Lu Y.-S.; Chiang C.-J.; Chen Y.-C.; Lin C.-H. |
| 臺大學術典藏 |
2020-03-23T07:19:18Z |
Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation
|
Wang C.-C.; Chang D.-Y.; CHIUN-SHENG HUANG; Cheng A.L.; Kuo K.-T.; Lee W.-C.; Lan C.; Lu Y.-S.; Lin C.-H.;Liu J.M.;Lu Y.-S.;Lan C.;Lee W.-C.;Kuo K.-T.;Wang C.-C.;Chang D.-Y.;Chiun-Sheng Huang;Cheng A.L.; Lin C.-H.; Liu J.M. |
| 臺大學術典藏 |
2020-03-23T07:19:16Z |
Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance
|
Lien H.-C.;Wang C.-C.;Lin C.-H.;Lu Y.-S.;Chiun-Sheng Huang;Hsiao L.-P.;Yao Y.-T.; Lien H.-C.; Wang C.-C.; Lin C.-H.; Lu Y.-S.; CHIUN-SHENG HUANG; Hsiao L.-P.; Yao Y.-T. |
| 臺大學術典藏 |
2020-03-23T07:19:15Z |
CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer
|
Kuo S.-H.;Yang S.-Y.;Lien H.-C.;Lo C.;Lin C.-H.;Lu Y.-S.;Cheng A.-L.;Chang K.-J.;Chiun-Sheng Huang; Kuo S.-H.; Yang S.-Y.; Lien H.-C.; Lo C.; Lin C.-H.; Lu Y.-S.; Cheng A.-L.; Chang K.-J.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2020-03-23T07:19:13Z |
Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based study
|
Lin C.-H.;Chuang P.-Y.;Chiang C.-J.;Lu Y.-S.;Cheng A.-L.;Kuo W.-H.;Chiun-Sheng Huang;Lai M.-S.;You S.-L.;Tang C.-H.; Lin C.-H.; Chuang P.-Y.; Chiang C.-J.; Lu Y.-S.; Cheng A.-L.; Kuo W.-H.; CHIUN-SHENG HUANG; Lai M.-S.; You S.-L.; Tang C.-H. |
| 臺大學術典藏 |
2020-03-23T07:19:12Z |
No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen
|
Chen T.W.-W.; Chen H.-M.; Lin C.-H.; CHIUN-SHENG HUANG; Cheng A.-L.; Lai M.-S.; Lu Y.-S. |
| 臺大學術典藏 |
2020-03-23T07:19:06Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Cheng A.-L.; Lu Y.-S.; Kuo S.-H.; Chen C.-J.; Wu P.-F.; Kuo K.-T.; Chen W.-W.; Chen I.-C.; Hsiung C.-N.; Chang D.-Y.; Kuo W.-H.; Yang C.-H.; Shen C.-Y.; Lee J.-H.; CHIUN-SHENG HUANG; Lin C.-H.; Lin C.-H.;Shen C.-Y.;Lee J.-H.;Chiun-Sheng Huang;Yang C.-H.;Kuo W.-H.;Chang D.-Y.;Hsiung C.-N.;Kuo K.-T.;Chen W.-W.;Chen I.-C.;Wu P.-F.;Kuo S.-H.;Chen C.-J.;Lu Y.-S.;Cheng A.-L. |
| 臺大學術典藏 |
2020-03-23T07:19:05Z |
Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient
|
Chang Y.-C.; Chen J.-Y.; Chen H.-H.; CHIUN-SHENG HUANG; Lu Y.-S.; Chang R.-F.; Wu L.-A. |
| 臺大學術典藏 |
2020-03-23T07:19:01Z |
Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1–2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy
|
Lai S.-F.; Chen Y.-H.; Kuo W.-H.; Lien H.-C.; Wang M.-Y.; Lu Y.-S.; Lo C.; Kuo S.-H.; Cheng A.-L.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2020-03-23T07:19:01Z |
Luteal versus follicular phase surgical oophorectomy plus tamoxifen in premenopausal women with metastatic hormone receptor-positive breast cancer
|
Adebamowo C.; Sun J.-Z.; Fei F.; Shao Z.-M.; Liu Y.; Akram Hussain S.Md.; Zhang B.; Cheng L.; Panigaro S.; Walta F.; Chuan J.H.; Mirasol-Lumague M.R.; Yip C.-H.; Navarro N.S.; Jr.; CHIUN-SHENG HUANG; Lu Y.-S.; Ferdousy T.; Salim R.; Akhter C.; Nahar S.; Uy G.; Young G.S.; Hade E.M.; Jarjoura D.; Siguan S.S.S.; Mostafa M.G.; Laudico A.V.; Love R.R.; Hossain S.M.; Hussain Md.M. |
| 臺大學術典藏 |
2020-03-23T07:18:54Z |
The breast graded prognostic assessment is associated with the survival outcomes in breast cancer patients receiving whole brain re-irradiation
|
Hsu C.-Y.; Lien H.-C.; Lu Y.-S.; CHIUN-SHENG HUANG; Kuo S.-H.; Liang T.H.-K.; Chen Y.-H.; Lai S.-F.; Lai S.-F.;Chen Y.-H.;Liang T.H.-K.;Hsu C.-Y.;Lien H.-C.;Lu Y.-S.;Chiun-Sheng Huang;Kuo S.-H. |
| 臺大學術典藏 |
2020-03-23T07:18:47Z |
Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population
|
Im S.-A.; Naito Y.; Yeo W.; Ueno T.; Kwong A.; Li H.; Huang S.-M.; Leung R.; Han W.; Tan B.; Hu F.-C.; CHIUN-SHENG HUANG; Cheng A.-L.; Lu Y.-S.; Asian Breast Cancer Cooperative Group; Lee K.-H.; Yap Y.S.; Lin C.-H. |
| 臺大學術典藏 |
2020-03-23T07:18:46Z |
Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations
|
Lin C.-H.; Lu T.-P.; Kuo C.-W.; Chen I.-C.; Chao M.; Wang M.-Y.; Kuo W.-H.; Cheng A.-L.; CHIUN-SHENG HUANG; Lu Y.-S.; Chen C.-H.; Chen C.-H.;Lu Y.-S.;Cheng A.-L.;Chiun-Sheng Huang;Kuo W.-H.;Wang M.-Y.;Chao M.;Chen I.-C.;Kuo C.-W.;Lu T.-P.;Lin C.-H. |
| 臺大學術典藏 |
2020-03-07T06:48:19Z |
The Association of Infrared Imaging Findings of the Breast with Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status of Breast Cancer
|
Chien K.-L.; Tsai Y.-S.; Chang K.-J.; TSUI-LIEN MAO; Lin C.-H.; Kuo W.-H.; Lu Y.-S.; Chen C.-Y.; Wang J. ;Shih T.T.F. ;Yen R.-F. ;Lu Y.-S. ;Chen C.-Y. ;Tsui-Lien Mao ;Lin C.-H. ;Kuo W.-H. ;Tsai Y.-S. ;Chang K.-J. ;Chien K.-L.; Wang J.; Shih T.T.F.; Yen R.-F. |
| 臺大學術典藏 |
2020-03-07T06:42:17Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Shao Y.-Y.;Kuan-Ting Kuo;Hu F.-C.;Lu Y.-S.;Huang C.-S.;Liau J.-Y.;Lee W.-C.;Hsu C.;Kuo W.-H.;Chang K.-J.;Lin C.-H.;Cheng A.-L.; Shao Y.-Y.; KUAN-TING KUO; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; Chang K.-J.; Lin C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-07T06:42:16Z |
O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers
|
Wu P.-F.;Kuan-Ting Kuo;Kuo L.-T.;Lin Y.-T.;Lee W.-C.;Lu Y.-S.;Yang C.-H.;Wu R.-M.;Tu Y.-K.;Tasi J.-C.;Tseng H.-M.;Tseng S.-H.;Cheng A.-L.;Lin C.-H.; Wu P.-F.; KUAN-TING KUO; Kuo L.-T.; Lin Y.-T.; Lee W.-C.; Lu Y.-S.; Yang C.-H.; Wu R.-M.; Tu Y.-K.; Tasi J.-C.; Tseng H.-M.; Tseng S.-H.; Cheng A.-L.; Lin C.-H. |
| 臺大學術典藏 |
2020-03-07T06:42:14Z |
Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients?
|
Cheng A.-L.; Lin C.-H. ;Lu Y.-S. ;Huang C.-S. ;Kuan-Ting Kuo ;Wang C.-C. ;You S.-L. ;Lin P.-H. ;Chang D.-Y. ;Kuo W.-H. ;Chang K.-J. ;Cheng A.-L.; Lin C.-H.; Lu Y.-S.; Huang C.-S.; KUAN-TING KUO; Wang C.-C.; You S.-L.; Lin P.-H.; Chang D.-Y.; Kuo W.-H.; Chang K.-J. |
| 臺大學術典藏 |
2020-03-07T06:42:13Z |
Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation
|
Lin C.-H.; Liu J.M.; Lu Y.-S.; Lan C.; Lee W.-C.; KUAN-TING KUO; Wang C.-C.; Chang D.-Y.; Huang C.-S.; Cheng A.L. |
